Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Fatigue 3Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Uterine Neoplasms 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Psychological Well-Being 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Malignant Hepatobiliary Neoplasm 1Lymphoma 1Lung Neoplasms 1Leukemia 1Glioblastoma 1Depression 1Colorectal Neoplasms 1Cognitive Dysfunction 1Caregiver Burden 1Anxiety Disorders 1

Interventions

ponatinib 1Telemedicine 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Hepatobiliary Neoplasm × Acceptance and Commitment Therapy × Gastrointestinal × Clear all
NCT07124546 2025-08-15

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Mayo Clinic

Phase NA Recruiting
60 enrolled
Gastrointestinal

Malignant Hepatobiliary Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡